Pancreatic Cancer Research

ResearcherHFR Freiburg KantonsspitalActive in the last 2 years

Léo Bühler

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2572-7487; OpenAlex author ID A5103138140. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sect… Last author DOI 10.2196/76811↗
  2. Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. Co-author DOI 10.1371/journal.pone.0252397↗
  3. New Isotopes for the Treatment of Pancreatic Cancer in Collaboration With CERN: A Mini Review. First author DOI 10.3389/fmed.2021.674656↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudia Mellenthin · 2 shared papers, 2021–2025 · strength 0.40
  2. Sarah Peisl · 2 shared papers, 2021–2025 · strength 0.40
  3. Cornelia Schneider · 1 shared paper, 2025 · strength 0.25
  4. Iréne Esposito · 1 shared paper, 2025 · strength 0.25
  5. Claudia Burkhardt · 1 shared paper, 2021 · strength 0.19
  6. Thierry Storà · 1 shared paper, 2021 · strength 0.19
  7. Bernhard Egger · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.